PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2014 October; 5(4): e0028. ISSN: 2076-9172Published online 2014 October 29. doi: 10.5041/RMMJ.10162.

Table 1.

Current Indications for Autologous and Allogeneic Stem Cell Transplantation.

	*Autologous Transplantation^{^}**	Allogeneic Transplantation^{^†}
Malignancies	Multiple myeloma	Acute myeloid leukemia
	Non-Hodgkin lymphoma	Acute lymphoblastic leukemia
	Hodgkin disease	Chronic myeloid leukemia
	Acute myeloid leukemia	Myelodysplastic syndromes
	Neuroblastoma	Myeloproliferative neoplasms
	Ovarian cancer	Non-Hodgkin lymphoma
	Germ-cell tumors	Hodgkin disease
		Multiple myeloma
		Juvenile chronic myeloid leukemia
Non-malignant disorders	Autoimmune disease	Aplastic anemia
	Amyloidosis	Paroxysmal nocturnal hemoglobinuria
		Fanconi’s anemia
		Diamond-Blackfan anemia
		Thalassemia major
		Sickle cell anemia
		Severe combined immunodeficiency
		Wiskott–Aldrich syndrome
		Inborn errors of metabolism
		Congenital neutropenia syndromes

^*More than 30,000 autologous transplantations are performed annually worldwide, two-thirds for multiple myeloma or non-Hodgkin lymphoma.

^†More than 24,000 allogeneic transplantations are performed annually worldwide, more than half for acute leukemias.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2014 October; 5(4): e0028. ISSN: 2076-9172

Published online 2014 October 29. doi: 10.5041/RMMJ.10162